Showing results (1-10 of 62) with videos related to
Sort By:
Pageof 7
Seminars in Oncology|February 26, 2004
Pemetrexed for treatment of advanced non-small cell lung cancerFrank V FossellaClinical Lung Cancer|January 15, 2004
Docetaxel in second-line treatment of non-small-cell lung cancerFrank V FossellaOncology (Williston Park, N.Y.)|July 11, 2002
Docetaxel for previously treated non-small-cell lung cancerFrank V FossellaJournal of the Advanced Practitioner in Oncology|December 29, 2017
Biomarkers/Molecular Targets, Immunotherapy, and Treatments for Non-Small Cell Lung CancerElizabeth S Waxman, Frank V FossellaSeminars in Oncology|February 26, 2004
Targeted molecules in small cell lung cancerNevin Murray, Ravi Salgia, Frank V FossellaLung Cancer (Amsterdam, Netherlands)|December 14, 2002
Second line chemotherapy for NSCLC: establishing a gold standardFrank V Fossella, Thomas Lynch, Frances A ShepherdOncology (Williston Park, N.Y.)|September 2, 2004
Pemetrexed in advanced NSCLC: a review of the clinical dataRalph G Zinner, Frank V Fossella, Roy S HerbstInternational Journal of Radiation Oncology, Biology, Physics|April 15, 2011
Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancerShervin M Shirvani, Ritsuko Komaki, John V Heymach, et al.Seminars in Oncology|February 1, 2017
Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: A review of two phase III trialsFrances A Shepherd, Frank V Fossella, Thomas Lynch, et al.Pageof 7